ÂÜÀòÂÒÂ×

Geoff Nosrati currently serves as the Chief Business Officer at Synthekine since October 2023. Previously, Geoff held the same title at Nutcracker Therapeutics from January 2022 to October 2023, and at ImmunoScape from October 2020 to January 2022. Prior roles include senior positions at Aduro Biotech, where Geoff was SVP of Strategy and Corporate Development and Vice President of various strategic roles from August 2015 to March 2020, as well as Chief of Staff to the CEO. Geoff's earlier experience includes working as an Engagement Manager at McKinsey & Company from August 2012 to August 2015, and as a Senior Research Associate at Kosan Biosciences, along with positions at Genesoft Pharmaceuticals. Geoff earned a Ph.D. in Biochemistry and Molecular Biology from UCLA and a B.S. in Chemistry from Duke University.